Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Anish Ray"'
Autor:
Natalia Wojciechowska, Kaci Orr, Karen Albritton, Kenneth Heym, Kelly Vallance, Lauren Murray, Rocio Aguilar, Anish Ray
Publikováno v:
Hemato, Vol 5, Iss 1, Pp 66-80 (2024)
Immunotherapy has emerged as a promising treatment approach in oncology, as it is specifically designed to boost the strength and accuracy of the immune system, allowing it to target tumor cells but spare non-tumor tissue. This treatment not only dem
Externí odkaz:
https://doaj.org/article/5eb005959b854d6fac40bbdd802d340b
Autor:
Angela Liu, Paige Vicenzi, Ishna Sharma, Kaci Orr, Christa Teller, Micha Koentz, Heidi Trinkman, Kelly Vallance, Anish Ray
Publikováno v:
Hematology Reports, Vol 15, Iss 2, Pp 244-255 (2023)
The application of molecular tumor profiles in clinical decision making remains a challenge. To aid in the interpretation of complex biomarkers, molecular tumor boards (MTBs) have been established worldwide. In the present study, we show that a multi
Externí odkaz:
https://doaj.org/article/a6931db0fe19455eb970c982e6234b49
Autor:
Ishna Sharma, Min Ji Son, Shoaleh Motamedi, Alice Hoeft, Christa Teller, Tyler Hamby, Anish Ray
Publikováno v:
Hematology Reports, Vol 15, Iss 2, Pp 256-265 (2023)
Hematologic tumors are mostly treated with chemotherapies that have poor toxicity profiles. While molecular tumor profiling can expand therapeutic options, our understanding of potential targetable drivers comes from studies of adult liquid tumors, w
Externí odkaz:
https://doaj.org/article/e98f6236d56a46f8af6bda5b4d1c5919
Autor:
Eily Cournoyer, Justin Ferrell, Susan Sharp, Anish Ray, Michael Jordan, Christopher Dandoy, Michael Grimley, Somak Roy, Robert Lorsbach, Arnold C. Merrow, Adam Nelson, Allison Bartlett, Jennifer Picarsic, Ashish Kumar
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
The standard treatment for Langerhans cell histiocytosis (LCH) is chemotherapy, although the failure rates are high. Since MAP-kinase activating mutations are found in most cases, BRAF- and MEK-inhibitors have been used successfully to treat patients
Externí odkaz:
https://doaj.org/article/3a8f57d42793462f81307b1aba0abd07
Publikováno v:
Clinical Pediatric Hematology-Oncology, Vol 29, Iss 2, Pp 60-64 (2022)
In 2012, a new neoplasm was classified according to fusion of the B-cell lymphoma (BCL-6) corepressor (BCOR) gene and the testis-specific cyclin B3 (CCNB3) gene on the X-chromosome, known as a BCOR-CCNB3 fusion positive sarcoma. Traditionally, BCOR s
Externí odkaz:
https://doaj.org/article/9c5cbeeb672d4376a492a6009240cc27
Autor:
Angela Liu, Anish Ray
Publikováno v:
Bone Reports, Vol 15, Iss , Pp 101135- (2021)
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique re
Externí odkaz:
https://doaj.org/article/6801d6b73cb14ae486708c4e2467dff4
Autor:
Ishna Sharma, Tyler Hamby, Sahil Noorani, Angela Liu, Salma Omar, Hufsa Ahmad, Shelley Watts, Alice Hoeft, Suzanne Whitworth, Anish Ray
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e304-e308
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e479-e482
Autor:
Shelley Watts, Maranda Diaz, Christa Teller, Tyler Hamby, Ricardo Guirola, Maria Perez, Gretchen Eames, Richard Howrey, Ana Rios, Heidi Trinkman, Anish Ray
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e328-e333
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e534-e538